Annual D&A
$16.00 M
+$3.67 M+29.74%
December 31, 2024
Summary
- As of March 12, 2025, CSTL annual depreciation & amortization is $16.00 million, with the most recent change of +$3.67 million (+29.74%) on December 31, 2024.
- During the last 3 years, CSTL annual D&A has risen by +$12.59 million (+369.53%).
- CSTL annual D&A is now at all-time high.
Performance
CSTL Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$5.77 M
+$2.23 M+62.89%
December 31, 2024
Summary
- As of March 12, 2025, CSTL quarterly depreciation & amortization is $5.77 million, with the most recent change of +$2.23 million (+62.89%) on December 31, 2024.
- Over the past year, CSTL quarterly D&A has increased by +$2.54 million (+78.91%).
- CSTL quarterly D&A is now at all-time high.
Performance
CSTL Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$16.00 M
+$2.54 M+18.91%
December 31, 2024
Summary
- As of March 12, 2025, CSTL TTM depreciation & amortization is $16.00 million, with the most recent change of +$2.54 million (+18.91%) on December 31, 2024.
- Over the past year, CSTL TTM D&A has increased by +$3.67 million (+29.74%).
- CSTL TTM D&A is now at all-time high.
Performance
CSTL TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
CSTL Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +29.7% | +78.9% | +29.7% |
| 3 y3 years | +369.5% | +78.9% | +29.7% |
| 5 y5 years | +4368.4% | +78.9% | +29.7% |
CSTL Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +369.5% | at high | +297.5% | at high | +369.5% |
| 5 y | 5-year | at high | +4368.4% | at high | +6238.5% | at high | +4368.4% |
| alltime | all time | at high | +5047.0% | at high | +7155.4% | at high | >+9999.0% |
Castle Biosciences Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $16.00 M(+29.7%) | $5.77 M(+62.9%) | $16.00 M(+18.9%) |
| Sep 2024 | - | $3.54 M(+5.8%) | $13.45 M(+2.8%) |
| Jun 2024 | - | $3.35 M(+0.2%) | $13.09 M(+2.4%) |
| Mar 2024 | - | $3.34 M(+3.6%) | $12.78 M(+3.6%) |
| Dec 2023 | $12.33 M(+16.9%) | $3.22 M(+1.6%) | $12.33 M(+3.2%) |
| Sep 2023 | - | $3.17 M(+4.4%) | $11.95 M(+2.1%) |
| Jun 2023 | - | $3.04 M(+5.1%) | $11.70 M(+3.7%) |
| Mar 2023 | - | $2.89 M(+1.8%) | $11.28 M(+7.0%) |
| Dec 2022 | $10.54 M(+209.5%) | $2.84 M(-2.8%) | $10.54 M(+15.2%) |
| Sep 2022 | - | $2.92 M(+11.2%) | $9.15 M(+25.1%) |
| Jun 2022 | - | $2.63 M(+22.2%) | $7.32 M(+37.4%) |
| Mar 2022 | - | $2.15 M(+48.2%) | $5.33 M(+56.3%) |
| Dec 2021 | $3.41 M | $1.45 M(+33.2%) | $3.41 M(+61.0%) |
| Sep 2021 | - | $1.09 M(+71.8%) | $2.12 M(+84.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | $634.00 K(+172.1%) | $1.15 M(+86.6%) |
| Mar 2021 | - | $233.00 K(+45.6%) | $614.00 K(+30.1%) |
| Dec 2020 | $472.00 K(+31.8%) | $160.00 K(+34.5%) | $472.00 K(+14.6%) |
| Sep 2020 | - | $119.00 K(+16.7%) | $412.00 K(+7.3%) |
| Jun 2020 | - | $102.00 K(+12.1%) | $384.00 K(+4.1%) |
| Mar 2020 | - | $91.00 K(-9.0%) | $369.00 K(+3.1%) |
| Dec 2019 | $358.00 K(+10.8%) | $100.00 K(+9.9%) | $358.00 K(+6.1%) |
| Sep 2019 | - | $91.00 K(+4.6%) | $337.50 K(+2.3%) |
| Jun 2019 | - | $87.00 K(+8.8%) | $329.80 K(+2.0%) |
| Mar 2019 | - | $80.00 K(+0.6%) | $323.20 K(+0.1%) |
| Dec 2018 | $323.00 K(+3.9%) | $79.50 K(-4.6%) | $323.00 K(+32.6%) |
| Sep 2018 | - | $83.30 K(+3.6%) | $243.50 K(+52.0%) |
| Jun 2018 | - | $80.40 K(+0.8%) | $160.20 K(+100.8%) |
| Mar 2018 | - | $79.80 K | $79.80 K |
| Dec 2017 | $310.80 K | - | - |
FAQ
- What is Castle Biosciences annual depreciation & amortization?
- What is the all time high annual D&A for Castle Biosciences?
- What is Castle Biosciences annual D&A year-on-year change?
- What is Castle Biosciences quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Castle Biosciences?
- What is Castle Biosciences quarterly D&A year-on-year change?
- What is Castle Biosciences TTM depreciation & amortization?
- What is the all time high TTM D&A for Castle Biosciences?
- What is Castle Biosciences TTM D&A year-on-year change?
What is Castle Biosciences annual depreciation & amortization?
The current annual D&A of CSTL is $16.00 M
What is the all time high annual D&A for Castle Biosciences?
Castle Biosciences all-time high annual depreciation & amortization is $16.00 M
What is Castle Biosciences annual D&A year-on-year change?
Over the past year, CSTL annual depreciation & amortization has changed by +$3.67 M (+29.74%)
What is Castle Biosciences quarterly depreciation & amortization?
The current quarterly D&A of CSTL is $5.77 M
What is the all time high quarterly D&A for Castle Biosciences?
Castle Biosciences all-time high quarterly depreciation & amortization is $5.77 M
What is Castle Biosciences quarterly D&A year-on-year change?
Over the past year, CSTL quarterly depreciation & amortization has changed by +$2.54 M (+78.91%)
What is Castle Biosciences TTM depreciation & amortization?
The current TTM D&A of CSTL is $16.00 M
What is the all time high TTM D&A for Castle Biosciences?
Castle Biosciences all-time high TTM depreciation & amortization is $16.00 M
What is Castle Biosciences TTM D&A year-on-year change?
Over the past year, CSTL TTM depreciation & amortization has changed by +$3.67 M (+29.74%)